Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,575 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Letter to the Editor regarding Response to "Letter to Editor: "Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19".
Takazono T, Fujita S, Komeda T, Miyazawa S, Yoshida Y, Kitanishi Y, Kinoshita M, Kojima S, Shen H, Uehara T, Hosogaya N, Iwanaga N, Mukae H. Takazono T, et al. Among authors: fujita s. Infect Dis Ther. 2024 Nov;13(11):2463-2467. doi: 10.1007/s40121-024-01054-6. Epub 2024 Sep 27. Infect Dis Ther. 2024. PMID: 39331323 Free PMC article. No abstract available.
Comparison of Intra-Familial Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Oseltamivir Using an Influenza Transmission Model and a Health Insurance Claims Database.
Miyazawa S, Takazono T, Hosogaya N, Yamamoto K, Watanabe H, Fujiwara M, Fujita S, Mukae H. Miyazawa S, et al. Among authors: fujita s. Clin Infect Dis. 2022 Sep 29;75(6):927-935. doi: 10.1093/cid/ciac068. Clin Infect Dis. 2022. PMID: 35100617 Free PMC article.
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case.
Kuwata T, Kaku Y, Biswas S, Matsumoto K, Shimizu M, Kawanami Y, Uraki R, Okazaki K, Minami R, Nagasaki Y, Nagashima M, Yoshida I, Sadamasu K, Yoshimura K, Ito M, Kiso M, Yamayoshi S, Imai M, Ikeda T, Sato K, Toyoda M, Ueno T, Inoue T, Tanaka Y, Kimura KT, Hashiguchi T, Sugita Y, Noda T, Morioka H, Kawaoka Y, Matsushita S; Genotype to Phenotype Japan (G2P-Japan) Consortium. Kuwata T, et al. EBioMedicine. 2024 Nov 1;110:105439. doi: 10.1016/j.ebiom.2024.105439. Online ahead of print. EBioMedicine. 2024. PMID: 39488016 Free PMC article.
The Evolution and Clinical Impact of Deep Learning Technologies in Breast MRI.
Fujioka T, Fujita S, Ueda D, Ito R, Kawamura M, Fushimi Y, Tsuboyama T, Yanagawa M, Yamada A, Tatsugami F, Kamagata K, Nozaki T, Matsui Y, Fujima N, Hirata K, Nakaura T, Tateishi U, Naganawa S. Fujioka T, et al. Among authors: fujita s. Magn Reson Med Sci. 2024 Oct 29. doi: 10.2463/mrms.rev.2024-0056. Online ahead of print. Magn Reson Med Sci. 2024. PMID: 39477506 Free article.
3,575 results